NASDAQ: ANIX
Anixa Biosciences Inc Stock Forecast, Predictions & Price Target

Analyst price target for ANIX

Based on 3 analysts offering 12 month price targets for Anixa Biosciences Inc

Min Forecast
$7.00+153.62%
Avg Forecast
$9.00+226.09%
Max Forecast
$10.00+262.32%

Should I buy or sell ANIX stock?

Based on 3 analysts offering ratings for Anixa Biosciences Inc.

Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ANIX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ANIX as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their ANIX stock forecasts and price targets.

ANIX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-10
lockedlocked$00.00+00.00%2025-03-25
lockedlocked$00.00+00.00%2025-03-21

1 of 1

Forecast return on equity

Is ANIX forecast to generate an efficient return?

Company
N/A
Industry
83.02%
Market
61.4%

Forecast return on assets

Is ANIX forecast to generate an efficient return on assets?

Company
N/A
Industry
23.08%

ANIX earnings per share forecast

What is ANIX's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$0.41
Avg 2 year Forecast
-$0.40

ANIX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ANIX$2.76$9.00+226.09%Strong Buy
XBIT$2.91N/AN/A
PLRX$1.46$8.79+501.78%Hold
EXOZ$10.73N/AN/A
MCRB$10.08$80.00+693.65%Buy

Anixa Biosciences Stock Forecast FAQ

Is Anixa Biosciences Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: ANIX) stock is to Strong Buy ANIX stock.

Out of 3 analysts, 2 (66.67%) are recommending ANIX as a Strong Buy, 1 (33.33%) are recommending ANIX as a Buy, 0 (0%) are recommending ANIX as a Hold, 0 (0%) are recommending ANIX as a Sell, and 0 (0%) are recommending ANIX as a Strong Sell.

If you're new to stock investing, here's how to buy Anixa Biosciences stock.

What is ANIX's earnings growth forecast for 2025-2026?

(NASDAQ: ANIX) Anixa Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 17.98%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 23.17%.

Anixa Biosciences's earnings in 2025 is -$12,483,000.On average, 1 Wall Street analyst forecast ANIX's earnings for 2025 to be -$13,200,713, with the lowest ANIX earnings forecast at -$13,200,713, and the highest ANIX earnings forecast at -$13,200,713.

In 2026, ANIX is forecast to generate -$12,878,745 in earnings, with the lowest earnings forecast at -$12,878,745 and the highest earnings forecast at -$12,878,745.

What is ANIX's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: ANIX) forecast ROE is N/A, which is considered weak.

What is ANIX's Price Target?

According to 3 Wall Street analysts that have issued a 1 year ANIX price target, the average ANIX price target is $9.00, with the highest ANIX stock price forecast at $10.00 and the lowest ANIX stock price forecast at $7.00.

On average, Wall Street analysts predict that Anixa Biosciences's share price could reach $9.00 by Apr 10, 2026. The average Anixa Biosciences stock price prediction forecasts a potential upside of 226.09% from the current ANIX share price of $2.76.

What is ANIX's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: ANIX) Anixa Biosciences's current Earnings Per Share (EPS) is -$0.39. On average, analysts forecast that ANIX's EPS will be -$0.41 for 2025, with the lowest EPS forecast at -$0.41, and the highest EPS forecast at -$0.41. In 2026, ANIX's EPS is forecast to hit -$0.40 (min: -$0.40, max: -$0.40).

What is ANIX's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: ANIX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 23.08%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.